Registered Charity No. 1088008.

 

 
Chairman's Report
 
 

 

Conference 2007

back to Programme

THE ROLE OF ENDOTHELIUM IN ERECTILE DISSATISFACTION

Andrea Garolla and Carlo Foresta

Department of Histology, Microbiology and Medical Biotechnologies, Centre for Male Gamete Cryopreservation, University of Padua, Italy. andrea.garolla@unipd.it

Endothelial dysfunction seems to be the first step of the atherosclerotic process. In the past few years, it has been demonstrated that injured endothelial monolayer is restored by a premature pool of circulating progenitor cells (PCs) and a more mature one of circulating endothelial progenitor cells (EPCs). Patients affected by erectile dysfunction (ED) have low levels of both PCs and EPCs and a subtle endothelial alteration has been suggested in these subjects.

Even thought there are increasing evidence that estrogens play a beneficial role on EPCs and, even if debated, on the cardiovascular system, less is known about androgens. Despite it is well known that testosterone has a mandatory role in both central and peripheral modulation of erection, basics of its action are still not completely understood. Here we investigate the possible Testosterone action on the regulation of endothelial function and thus on erection.

We evaluated the levels of circulating PCs and EPCs in 10 ED men (28.6+3.1 years) due to hypogonadotropic hypogonadism (HH) and in 25 age-matched controls. Furthermore, on patients we evaluated the effect of a prolonged testosterone (T) replacement therapy (testosterone gel therapy, 50mg/day for 6 months) on PCs and EPCs concentrations, immunocytochemistry for androgen receptor (AR) on cultured EPCs and on erectile function.

At baseline HH patients showed a significant reduction of both PCs and EPCs with respect to controls. T replacement therapy induced a significant improvement of erectile performances and an increase of PCs and EPCs with respect to baseline. Immunocytochemistry on cultured EPCs showed strong expression of the AR.

In conclusion, hypotestosteronemia is associated with a low number of circulating PCs and EPCs in young HH subjects that could be the responsible of a subtle endothelial dysfunction and thus of ED. Testosterone treatment is able to induce an increase in PCs and EPCs through a possible direct effect on the bone marrow.